Range
6.73 - 7.96
Vol / Avg.
8.4M/985.7K
Div / Yield
-
52 Wk
6.73 - 24.3
Mkt Cap
529.2M
Payout Ratio
-
Open
7.89
P/E
-
EPS
-0.11
Shares
76.6M
Outstanding
76.6M
Total Float
68.7M
load more
Sector: Health Care.Industry: Pharmaceuticals
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Ocular Therapeutix aims to offer medication to replace the existing eye-drop therapy regimen, with the aim of lasting weeks or months with a one-time product application. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, PTX-TP, and OTX-IVT.

Earnings

see more
Q3 2021Est.ActualSurprise
EPS
(EXPECTED)2021-11-04
REV
Q2 2021Est.ActualSurprise
EPS-0.210-0.250 -0.0400
REV11.600M11.718M118.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Ocular Therapeutix Questions & Anwsers

Q

How do I buy Ocular Therapeutix (OCUL) stock?

A

You can purchase shares of Ocular Therapeutix (NASDAQ: OCUL) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Ocular Therapeutix's (OCUL) competitors?

Q

What is the target price for Ocular Therapeutix (OCUL) stock?

A

The latest price target for Ocular Therapeutix (NASDAQ: OCUL) was reported by Raymond James on October 18, 2021. The analyst firm set a price target for 29.00 expecting OCUL to rise to within 12 months (a possible 319.68% upside). 6 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Ocular Therapeutix (OCUL)?

A

The stock price for Ocular Therapeutix (NASDAQ: OCUL) is $6.91 last updated Fri Oct 22 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Ocular Therapeutix (OCUL) pay a dividend?

A

There are no upcoming dividends for Ocular Therapeutix.

Q

When is Ocular Therapeutix (NASDAQ:OCUL) reporting earnings?

A

Ocular Therapeutix’s $Q3 earnings are confirmed for after-market on $November 4, 2021.

Q

Is Ocular Therapeutix (OCUL) going to split?

A

There is no upcoming split for Ocular Therapeutix.

Q

What sector and industry does Ocular Therapeutix (OCUL) operate in?

A

Ocular Therapeutix is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.